Ethics for artificial intelligence use in clinical pharmacology
Amnuay Kleebayoon, Viroj Wiwanitkit · Indian Journal of Pharmacology · 2024
Dear Editor, To ensure the responsible and ethical deployment of artificial intelligence (AI) in health-care settings, ethics for AI usage in clinical pharmacology are critical. AI has the ability to significantly alter clinical pharmacology by providing a variety of benefits and applications.[1,2] Here are a few examples of how AI is being applied in many sectors. To uncover prospective medication candidates, AI systems can examine massive volumes of data, such as molecular structures, biological pathways, and clinical trial results. This can help researchers pick molecules for further examination and speed up the drug discovery process. AI can find patterns and make individualized therapy suggestions by analyzing patient data such as genetic information, medical records, and treatment outcomes. This can help in identifying the most effective drugs and dosages for specific patients, resulting in better treatment outcomes. AI can help monitor and analyze adverse drug responses and safety data from a variety of sources, including electronic health records and social media. This can aid in the identification of potential safety issues and the early detection of adverse events connected with specific drugs. By assessing patient data and advising on proper prescription selections, doses, and potential drug interactions, AI systems can provide real-time guidance to health-care providers. This can improve clinical decision-making and patient safety. AI models can assess patient data to anticipate drug reactions, treatment outcomes, and probable side effects. This can help with treatment plan optimization, eliminating trial-and-error procedures, and increasing patient care. While AI has shown potential in clinical pharmacology, it should always be utilized in tandem with human skill and clinical judgment. When adopting AI in this industry, regulatory considerations, data privacy, and ethical consequences must all be properly considered. Here are several important factors. In clinical pharmacology, AI systems should be transparent and provide explanations for their decisions and suggestions. Health-care providers and patients should understand how the AI system reached its results. Patient data used in AI systems must be handled with extreme care and security. Compliance with applicable data protection rules, such as HIPAA, is critical for maintaining patient confidentiality. To avoid prejudice and promote fairness in treatment suggestions, AI systems should be created and trained. To avoid perpetuating current health-care disparities or discriminating against specific patient groups, caution must be taken. Patients should be informed about the use of AI systems in their care and have the right to express informed consent. They should be aware of the possible advantages, disadvantages, and limits of AI-based clinical pharmacology interventions. While AI can aid in clinical decision-making, human health-care practitioners should retain ultimate accountability and control. They should be taught to interpret and validate AI-generated recommendations to prioritize patient safety and well-being. It is critical to regularly monitor and evaluate the performance and impact of AI systems on patient outcomes. This assists in identifying and addressing any concerns, improving system accuracy, and maintaining the highest levels of care. Collaboration among health-care practitioners, pharmacologists, data scientists, ethicists, and other stakeholders is required for ethical AI application in clinical pharmacology. A multidisciplinary approach guarantees that ethical concerns are handled effectively. A multidisciplinary approach guarantees that ethical concerns are handled effectively. Following these ethical principles can help guarantee that AI technologies in clinical pharmacology are utilized responsibly, with patient welfare and ethical norms at the forefront. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.